Press release
Related Press

22 February 2024
CSEM and ClexBio create a bioreactor for tissue-engineered cardiovascular implants
The teams at CSEM and at ClexBio have developed a process for engineering vein grafts comprised of human tissue material that integrates into the patient’s body and can turn into real, living tissue....

3 September 2025
Breakthrough in mitochondria therapy: CSEM and cellvie automate isolation process for clinical use
cellvie and CSEM are advancing an automated solution to standardize mitochondrial therapy manufacturing, accelerating treatment for ischemia-reperfusion injury and potentially helping over 3 million p...

3 February 2023
Making personalized cancer therapies accessible to all
CSEM has supported Lausanne-based start-up Limula in its mission to make cell therapies more affordable, and to facilitate access to these personalized treatments. ...
